Xilio Therapeutics, Inc.
US ˙ NasdaqGS ˙ US98422T1007

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Timothy P Clackson. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Timothy P Clackson telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:ELEV / Elevation Oncology, Inc. Director 0
US: / THESEUS PHARMACEUTICALS INC President and CEO, Director 351,030
US:FMTX / Forma Therapeutics Holdings Inc Director 0
US:XLO / Xilio Therapeutics, Inc. 10% Owner 20,068
US:849CVR014 / CVR F STAR Director 50,486
US:ARIA / ARIAD Pharmaceuticals, Inc. President, R&D, CSO 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Timothy P Clackson. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam XLO / Xilio Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di XLO / Xilio Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

XLO / Xilio Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam XLO / Xilio Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di XLO / Xilio Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

XLO / Xilio Therapeutics, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Timothy P Clackson sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-07-24 2025-07-23 4 ELEV Elevation Oncology, Inc.
Common Stock
U - Other -47,330 0 -100.00 0.36 -17,039
2023-09-05 2023-09-01 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -15,777 0 -100.00
2022-11-14 2022-11-11 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2,500 351,030 0.72 6.80 16,995 2,386,302
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -7,250 0 -100.00
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -23,590 0 -100.00
2022-06-22 2022-05-31 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -31,553 15,777 -66.67
2022-06-09 2022-06-08 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 4,500 30,840 17.08
2022-02-23 2022-02-18 4 THRX Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 450,000 450,000
2021-12-22 2021-12-21 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2,600 348,530 0.75 9.76 25,381 3,402,385
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
20,068
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
70,888
2021-10-06 3 THRX Theseus Pharmaceuticals, Inc.
Common Stock
345,930
2021-06-24 3 ELEV Elevation Oncology, Inc.
Common Stock
47,330
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 8,375 8,375
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 2,750 26,340 11.66
2020-10-01 2020-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 9,422 50,486 22.94
2020-07-01 2020-06-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 8,588 41,064 26.44
2020-06-25 2020-06-24 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
S - Sale -35,067 0 -100.00
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Common Stock
P - Purchase 23,590 23,590
2020-06-22 2020-06-18 4 FMTX Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy)
A - Award 17,533 0 -100.00
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43,144
2020-04-01 2020-03-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 13,575 32,476 71.82
2020-01-02 2019-12-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 7,991 18,901 73.24
2019-10-01 2019-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3,670 10,910 50.69
2019-07-11 2019-07-10 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7,500 7,500
2019-07-01 2019-06-28 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3,421 7,240 89.58
2019-04-02 2019-03-29 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1,204 3,819 46.04
2019-01-03 2019-01-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1,083 2,615 70.69
2018-10-02 2018-10-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 788 1,532 105.91
2018-07-03 2018-07-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 744 744
2018-03-05 2018-03-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 11,000 11,000
2018-03-05 3 SBPH Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned
0
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -14,550 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -72,980 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -87,125 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -65,000 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -82,000 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -577 0 -100.00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -219,867 0 -100.00
2017-02-07 2017-02-06 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 14,550 14,550
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,333 0 -100.00
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -9,610 219,867 -4.19 23.82 -228,886 5,236,682
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,333 229,477 14.66
2016-10-25 2016-10-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19,638 197,884 -9.03 9.56 -187,739 1,891,771
2016-09-28 2016-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,750 217,522 -3.87 13.98 -122,311 3,040,610
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17,500 0 -100.00
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17,500 226,272 8.38
2016-09-23 2016-09-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 208,772 -8.74 13.43 -268,536 2,803,140
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -59,369 0 -100.00
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -59,369 228,772 -20.60 11.73 -696,398 2,683,496
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 59,369 288,141 25.95 7.82 464,266 2,253,263
2016-08-23 2016-08-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19,436 228,772 -7.83 10.47 -203,538 2,395,746
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -25,000 248,208 -9.15 10.50 -262,500 2,606,184
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 273,208 10.07 7.69 192,250 2,100,970
2016-07-25 2016-07-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -18,286 248,208 -6.86 8.11 -148,230 2,012,024
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30,000 0 -100.00 3.25 -97,500
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -31,422 0 -100.00 4.49 -141,085
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -30,000 266,494 -10.12 7.48 -224,481 1,994,095
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 30,000 296,494 11.26 3.25 97,500 963,606
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31,422 266,494 -10.55 7.48 -235,153 1,994,361
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 31,422 297,916 11.79 4.49 141,085 1,337,643
2016-06-23 2016-06-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,999 264,742 -8.31 7.28 -174,638 1,926,501
2016-05-25 2016-05-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -17,762 288,741 -5.80 8.08 -143,430 2,331,612
2016-05-02 2016-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -11,700 306,503 -3.68 7.13 -83,478 2,186,868
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -23,400 0 -100.00
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23,400 318,203 7.94
2016-04-25 2016-04-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -21,409 294,803 -6.77 7.37 -157,864 2,173,789
2016-03-23 2016-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,834 316,212 -7.01 6.58 -156,871 2,081,244
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,833 0 -100.00
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,417 340,046 -1.57 6.47 -35,039 2,199,520
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,833 345,463 3.24
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 26,180 26,180
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 87,125 87,125
2016-03-03 2016-03-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,625 334,630 -2.80 6.12 -58,867 2,046,631
2016-03-03 2016-03-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -25,047 344,255 -6.78 6.00 -150,282 2,065,530
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 38,500 38,500
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -19,250 19,250 -50.00
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,250 369,302 5.50
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,333 29,333 -50.00
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,667 350,052 -4.02 4.81 -70,517 1,683,015
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,333 364,719 8.75
2015-09-28 2015-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,750 334,086 -2.55 6.46 -56,560 2,159,532
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 35,000 35,000
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17,500 17,500 -50.00
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17,500 342,836 5.38
2015-07-16 2015-07-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,000 325,336 -2.11 8.54 -59,797 2,779,150
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14,000 0 -100.00
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14,000 332,336 4.40
2015-04-30 2015-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 70,200 70,200
2015-04-27 2015-04-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -123,766 316,548 -28.11 9.50 -1,175,777 3,007,206
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,333 0 -100.00
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,667 440,314 -1.49 8.55 -57,016 3,765,565
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,333 446,981 3.07
2015-03-23 2015-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,417 433,648 -1.23 8.84 -47,910 3,835,313
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20,657 0 -100.00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,833 10,833 -50.00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -20,657 440,314 -4.48 9.00 -185,913 3,962,826
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20,657 460,971 4.69 7.56 156,167 3,484,941
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,833 439,065 2.53
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24,036 31,422 -43.34
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24,999 0 -100.00
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24,036 428,232 -5.31 8.00 -192,288 3,425,856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24,036 452,268 5.61 4.49 107,922 2,030,683
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24,999 428,232 -5.52 8.00 -199,992 3,425,856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24,999 453,231 5.84 2.62 65,497 1,187,465
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29,334 58,666 -33.33
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,667 428,232 -3.31 6.33 -92,820 2,710,066
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29,334 442,899 7.09
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14,000 14,000 -50.00
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -4,564 413,565 -1.09 5.57 -25,421 2,303,557
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14,000 418,129 3.46
2014-04-03 2014-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,500 403,028 -1.59 8.21 -53,337 3,307,127
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 0 -100.00
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 409,528 3.28
2014-03-21 2014-03-21 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6,667 394,377 -1.66 7.89 -52,583 3,110,451
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,333 13,333 -50.00
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,333 401,044 3.44
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10,834 21,666 -33.34
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -3,442 387,711 -0.88 8.19 -28,190 3,175,353
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,834 391,153 2.85
2014-02-04 2014-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 88,000 88,000
2013-12-20 2013-12-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,750 380,319 -2.50 5.14 -50,115 1,954,840
2013-12-20 2013-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,500 390,069 5.26
2013-09-10 2013-09-06 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8,449 370,451 -2.23 22.00 -185,878 8,149,922
2013-07-18 2013-07-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14,000 378,900 -3.56 19.79 -277,045 7,498,014
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -28,000 28,000 -50.00
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 56,000 56,000
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 28,000 392,900 7.67
2013-04-03 2013-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6,500 363,705 -1.76 18.04 -117,245 6,560,402
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 0 -100.00
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 370,205 3.64
2013-03-26 2013-03-25 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -19,167 357,205 -5.09 18.87 -361,766 6,742,030
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38,333 0 -100.00
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38,333 376,372 11.34
2013-03-22 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6,667 338,039 -1.93 19.46 -129,718 6,577,123
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,334 0 -100.00
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,334 344,706 4.02
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 65,000 65,000
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 32,500 32,500
2013-03-05 2013-03-04 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9,838 331,372 -2.88 21.00 -206,598 6,958,812
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8,631 17,262 -33.33
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -44,542 0 -100.00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -4,766 0 -100.00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8,631 341,210 2.60 7.82 67,494 2,668,262
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 44,542 332,579 15.46 4.49 199,994 1,493,280
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 4,766 288,037 1.68 5.23 24,926 1,506,434
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -27,000 4,766 -85.00
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 27,000 282,940 10.55 5.23 141,210 1,479,776
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -8,142 255,940 -3.08 20.18 -164,306 5,164,869
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19,500 264,082 7.97
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -1 24,999 0.00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -10,000 30,000 -25.00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 1 244,170 0.00 2.62 3 639,725
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 244,169 4.27 3.25 32,500 793,549
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -36,843 0 -100.00
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -36,843 234,169 -13.59 20.00 -736,860 4,683,380
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 36,843 271,012 15.73 7.56 278,533 2,048,851
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -23,234 31,766 -42.24
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23,234 234,169 -9.03 19.00 -441,446 4,449,211
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23,234 257,403 9.92 5.23 121,514 1,346,218
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 233,778 -7.88 17.00 -340,000 3,974,226
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 253,778 8.56 7.44 148,800 1,888,108
2012-04-17 2012-04-17 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,111 233,778 -2.95 15.00 -106,665 3,506,670
2012-04-17 2012-04-13 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31,600 240,889 -11.60 14.83 -468,628 3,572,384
2012-04-03 2012-04-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5,200 272,489 -1.87 16.18 -84,134 4,408,763
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13,000 26,000 -33.33
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13,000 277,689 4.91
2012-04-03 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -26,061 264,689 -8.96 16.34 -425,876 4,325,415
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -7,500 0 -100.00
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 290,750 -2.51 16.00 -120,000 4,652,000
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 7,500 298,250 2.58 6.39 47,925 1,905,818
2012-03-26 2012-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -15,333 290,750 -5.01 15.41 -236,211 4,479,120
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38,333 38,333 -50.00
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38,333 306,083 14.32
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 40,000 40,000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 82,000 82,000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -36,400 267,750 -11.97 15.02 -546,622 4,020,829
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise 91,000 0 -100.00
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise -91,000 304,150 -23.03
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8,449 0 -100.00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6,615 0 -100.00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8,449 213,150 4.13 4.19 35,401 893,098
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 6,615 204,701 3.34 4.05 26,791 829,039
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16,500 16,500 -50.00
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41,551 8,449 -83.10
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -18,385 6,615 -73.54
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -76,436 119,882 -38.93 15.12 -1,155,781 1,812,724
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 16,500 196,318 9.18 3.90 64,350 765,640
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 41,551 179,818 30.05 4.19 174,099 753,437
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 18,385 138,267 15.34 4.05 74,459 559,981
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)